Exact Mass: 1494.7370854

Exact Mass Matches: 1494.7370854

Found 4 metabolites which its exact mass value is equals to given mass value 1494.7370854, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

PIM4 35:3

2-O-(alpha-D-Manp)-6-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z,12Z-nonadecadienoyl)-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1-myo-inositol)

C68H119O33P (1494.7370854)


   

Nociceptin (1-13), amide (TFA)

Nociceptin (1-13), amide (TFA)

C63H101F3N22O17 (1494.7666772)


Nociceptin (1-13), amide TFA is a potent ORL1 receptor (opioid receptor-like 1 receptor, OP4) agonist with a pEC50 of 7.9 for mouse vas deferens and a Ki of 0.75 nM for binding to rat forebrain membranes[1][2].

   

(2s,3s,4s,5s,6s)-6-[(1r,2r,4s,5r,8s,10s,13s,14r,17s,18r,21r,22r,23s)-2,23-dihydroxy-4,5,9,9,13,20,20-heptamethyl-21-{[(2z)-2-methylbut-2-enoyl]oxy}-22-{[(2z)-3-phenylprop-2-enoyl]oxy}-24-oxahexacyclo[15.5.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosan-10-yl]-4-{[(2s,3r,4s,5r,6r)-3-{[(2s,3r,4r,5r,6s)-4,5-dihydroxy-6-methyl-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3-hydroxy-5-{[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxane-2-carboxylic acid

(2s,3s,4s,5s,6s)-6-[(1r,2r,4s,5r,8s,10s,13s,14r,17s,18r,21r,22r,23s)-2,23-dihydroxy-4,5,9,9,13,20,20-heptamethyl-21-{[(2z)-2-methylbut-2-enoyl]oxy}-22-{[(2z)-3-phenylprop-2-enoyl]oxy}-24-oxahexacyclo[15.5.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosan-10-yl]-4-{[(2s,3r,4s,5r,6r)-3-{[(2s,3r,4r,5r,6s)-4,5-dihydroxy-6-methyl-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3-hydroxy-5-{[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxane-2-carboxylic acid

C74H110O31 (1494.703071)


   

(2s,3s,4s,5s,6s)-6-[(1r,2r,4s,5r,8s,10s,13s,14r,17s,18r,21r,22r,23s)-2,23-dihydroxy-4,5,9,9,13,20,20-heptamethyl-21-{[(2z)-2-methylbut-2-enoyl]oxy}-22-{[(2e)-3-phenylprop-2-enoyl]oxy}-24-oxahexacyclo[15.5.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosan-10-yl]-4-{[(2s,3r,4s,5r,6r)-3-{[(2s,3r,4r,5r,6s)-4,5-dihydroxy-6-methyl-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3-hydroxy-5-{[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxane-2-carboxylic acid

(2s,3s,4s,5s,6s)-6-[(1r,2r,4s,5r,8s,10s,13s,14r,17s,18r,21r,22r,23s)-2,23-dihydroxy-4,5,9,9,13,20,20-heptamethyl-21-{[(2z)-2-methylbut-2-enoyl]oxy}-22-{[(2e)-3-phenylprop-2-enoyl]oxy}-24-oxahexacyclo[15.5.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosan-10-yl]-4-{[(2s,3r,4s,5r,6r)-3-{[(2s,3r,4r,5r,6s)-4,5-dihydroxy-6-methyl-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3-hydroxy-5-{[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxane-2-carboxylic acid

C74H110O31 (1494.703071)